Pharma Equity Group A/S
PEG.CO · CPH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| Gross Profit | -DKK 0 | -DKK 0 | DKK 0 | DKK 0 |
| % Margin | – | – | – | – |
| R&D Expenses | DKK 9 | DKK 9 | DKK 0 | DKK 0 |
| G&A Expenses | DKK 0 | DKK 0 | DKK 2 | DKK 1 |
| SG&A Expenses | DKK 12 | DKK 16 | DKK 2 | DKK 1 |
| Sales & Mktg Exp. | DKK 0 | DKK 16 | DKK 0 | DKK 0 |
| Other Operating Expenses | DKK 0 | -DKK 0 | -DKK 5 | -DKK 6 |
| Operating Expenses | DKK 21 | DKK 25 | -DKK 3 | -DKK 5 |
| Operating Income | -DKK 21 | -DKK 25 | DKK 3 | -DKK 1 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -DKK 5 | -DKK 2 | DKK 0 | DKK 7 |
| Pre-Tax Income | -DKK 26 | -DKK 27 | DKK 3 | DKK 5 |
| Tax Expense | -DKK 2 | -DKK 2 | DKK 0 | DKK 0 |
| Net Income | -DKK 24 | -DKK 25 | DKK 3 | DKK 5 |
| % Margin | – | – | – | – |
| EPS | -0.023 | -0.023 | 0.093 | 0.097 |
| % Growth | -0.4% | -124.4% | -3.8% | – |
| EPS Diluted | -0.023 | -0.023 | 0.078 | 0.097 |
| Weighted Avg Shares Out | 1,068 | 1,080 | 37 | 56 |
| Weighted Avg Shares Out Dil | 1,068 | 1,080 | 44 | 56 |
| Supplemental Information | – | – | – | – |
| Interest Income | DKK 0 | DKK 0 | DKK 1 | DKK 1 |
| Interest Expense | DKK 5 | DKK 2 | DKK 1 | DKK 1 |
| Depreciation & Amortization | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| EBITDA | -DKK 21 | -DKK 25 | DKK 4 | DKK 6 |
| % Margin | – | – | – | – |